Pila Pharma AB (publ)

kr 1.58As of Sun 8 Nov 2026, 12:00 UTC
STO:PILAHealthcare
Country Sweden
PE (Fwd) •••
TSR 5Y CAGR (27.11%)
Div yield —
ROE (194.16%)
Biotechnology
Beta (5Y) (0.42)
PE TTM —
TSR TTM (26.96%)
Mkt cap kr 72.41M
ROIC (56.39%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 1.64
3.68%
(53.17%)
Hold 10|8|11|2|1
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.03
0.03
0.03
0.03
14.88%
16.75%
14.92%
2.68%
Revenuekr M
3.542
3.670
3.870
3.873
2.31%
9.11%
14.06%
15.13%
Peers (US$7.320M)
Cap (US$)
PE
6.612M
—
7.338M
—
Capital
TTM
5Y
10Y
Leveragex
0.198
0.055
0.050
EBIT/Intx
4.019
0.746
0.548
Own earn%
(102.98)
(63.65)
(49.20)
Sh yield%
19.38
60.17
58.12
Owners
Insiders/Inst%
7.61
49.46
Short interest%
3.62
SBC / revenue%
3.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
18–24
$1 testx
0.0
Incr. ROIC%
43